People · Operator
Named in public records as an officer, director or promoter · active 2013–2017 · Other Health Care, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| RxSight, Inc. | — | Other Health Care | Series C | $76.4M | $1.1B | 2017 |
| Run, Inc. | — | Other Technology | Seed | $1.5M | $51.1M | 2013 |
Dan Schwartz at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Dan Schwartz on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| William Link | 1 | 11 |
| Juliet Bakker | 1 | 9 |
| Bruce Robertson | 1 | 7 |
| JACK KAVANAUGH | 1 | 6 |
| J. Andy Corley | 1 | 5 |
| Shelley Thunen | 1 | 3 |
| Seth Hittman | 1 | 2 |
| Jan Bonel | 1 | 2 |
| Werner F. Wolfen | 1 | 2 |
| Daniel M. Schwartz | 1 | 2 |
| John Maynard | 1 | 2 |
| D. Verne Sharma | 1 | 2 |
| Chris Cox | 1 | 1 |
| Werner Wolfen | 1 | 1 |
| John D. Baxter | 1 | 1 |
| James N. Adler | 1 | 1 |
| Javier Perez-Sala | 1 | 1 |
| Robert H. Grubbs | 1 | 1 |
| Jan D. Bonel | 1 | 1 |
| Jack H. Kavanaugh | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.